Diabetes Treatments Push Beyond Weight Loss Into Addiction and Aging Trials

New York, Friday, 6 November 2026.
One in four new GLP-1 trials now targets non-metabolic diseases, tripling in 15 years as researchers test these blockbuster drugs against addiction, heart failure, and biological aging.